- Home
- PLRX vs FBIO Comparison
PLRX vs FBIO Comparison
Compare PLRX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | FBIO |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.7M | 80.4M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PLRX | FBIO |
|---|---|---|
| Price | $1.05 | $2.07 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 360.8K | 228.5K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.97 | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $24.55 |
| Revenue Next Year | N/A | $43.73 |
| P/E Ratio | ★ N/A | $0.76 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $1.02 | $2.14 |
| 52 Week High | $1.95 | $4.53 |
Technical Indicators
Market Signals| Indicator | PLRX | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 26.48 |
| Support Level | $1.02 | N/A |
| Resistance Level | $1.37 | $2.53 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 18.18 | 0.00 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.